Medical News

RSS

Menopause is not the end of women's love life

Menopause doesn't have to signal the end of a woman's love life. In fact, most women can enjoy even better sex after their reproductive years if they follow some healthy advice. Sex is good exercise and slows the aging process, so it's not only permissible but also smart to keep it a central part of one's lifestyle.

16 Aug 2010

Northstar Healthcare second-quarter net patient service revenue decreases to $4.4 million

Northstar Healthcare Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

16 Aug 2010

Scientists identify genes associated with aggressive breast cancer

Researchers at the University of Gothenburg, Sweden, have for the first time identified 12 genes that could be associated with aggressive breast tumours. The discovery could result in more reliable prognoses and better treatment strategies for patients.

16 Aug 2010

Opinions: PEPFAR funding; Aid in Africa; Obama, human rights

Following a recent letter by Sen. Richard Lugar (R-Ind.) to President Barack Obama that "expressed concern about the future of" PEPFAR "as details of the Obama administration's Global Health Initiative emerge," a Courier-Journal editorial looks at how the "U.S. made a commitment to be a major player in the worldwide fight against AIDS" and details how "arguably the most successful program implemented by President Bush" has made huge strides in broadening HIV treatment access and preventing mother-to-child-transmission in the developing world.

16 Aug 2010

Abnormalities in certain genes may cause autism: Research

Together with colleagues from an international research group, autism researcher Christopher Gillberg of the University of Gothenburg, Sweden, has found in a new study that autism can be partially explained by abnormalities in certain genes. The group's results could, in the long run, pave the way for more appropriate treatments for autism.

16 Aug 2010

Watson to launch ella emergency contraceptive in fourth-quarter 2010

Watson Pharmaceuticals, Inc., today announced that it intends to launch ella® (ulipristal acetate), a novel oral emergency contraceptive, in the fourth quarter of 2010. Watson's announcement follows the approval of ella® by the FDA as safe and effective in preventing unintended pregnancy for up to 120 hours – or five days – post-unprotected intercourse (UPI) or contraceptive failure.

16 Aug 2010

Researchers pace embryonic heart with laser

Scientists at Case Western Reserve University and Vanderbilt University found that pulsed light can pace contractions in an avian embryonic heart, with no apparent damage to the tissue. The work, "Optical pacing of the embryonic heart," will be published in the advanced online issue of Nature Photonics on Aug. 15, 2010.According to the scientists, this non-invasive device may prove an effective tool in understanding how environmental factors that alter an embryo's heart rate lead to congenital defects. It may also lead to investigations of cardiac electrophysiology at the cellular, tissue and organ levels, and possibly the development of a new generation of pacemakers.

16 Aug 2010

US WorldMeds announces acquisition of Solstice Neurosciences for $35M

US WorldMeds, LLC, a Kentucky-based specialty pharmaceutical company that develops unique products to address unmet medical needs, today announced it has acquired Solstice Neurosciences, Inc. for $35 million. The acquisition expands US WorldMeds' operations, adds to the company's growing portfolio of products and enhances the company's ability to create and deliver high-quality specialty pharmaceutical products to its targeted global markets.

16 Aug 2010

Delegates explore agricultural cooperation, expanded ties at two-day China-Africa Agricultural Forum

Chinese and African officials concluded the China-Africa Agricultural Forum in Beijing on Thursday, which explored possibilities for agricultural cooperation and addressed food security issues, Xinhua reports.

16 Aug 2010

Stockholders of Allscripts, Eclipsys approve fusion of two companies

Allscripts-Misys Healthcare Solutions, Inc. (Allscripts), the leading provider of clinical software, information and connectivity solutions for physicians, and Eclipsys Corporation ,a leading enterprise provider of solutions and services for hospitals and clinicians, today announced that stockholders of each company approved the merger of Allscripts and Eclipsys.

16 Aug 2010

FDA's labeling of Ella as 'Emergency Contraceptive' misleading, says FRC

Today the Food and Drug Administration (FDA) approved Ella, a drug that can cause abortions but is misleadingly labeled as a more effective "Emergency Contraceptive."

16 Aug 2010

MeCP2 protein regulates properties of psychostimulant drugs: Research

When a certain protein is mutated or missing, symptoms of the neurodevelopmental disorder Rett syndrome arise, causing a gradual loss of brain function during early development.This fact led Duke University Medical Center researchers to test a theory that the protein might also contribute to nerve-cell connection (synapse) changes in a fully formed adult mouse brain when exposed to psychostimulant use.

16 Aug 2010

Medicare fraudsters shift targets a la "whack-a-mole"

The Economist: In an effort to staunch the flow of up to $60 billion a year to Medicare fraudsters, federal officials are launching a series of new safeguards that target program areas favored by the con artists. "The Department of Health and Human Services is setting up data systems to monitor payments. A telephone-monitoring programme, with voice-recognition, will verify that health-care workers really are making home visits.

16 Aug 2010

Aeolus Pharmaceuticals second quarter 2010 net loss increases to $0.10 per share

Aeolus Pharmaceuticals, Inc. announced today financial results for the three months ended June 30, 2010. The Company reported a net loss of $4,623,000, or $0.10 per share, compared to a net loss of $426,000, or $0.01 per share, for the three months ended June 30, 2009. The third quarter 2010 results include a non-cash financing and change in valuation charge of $3,856,000. Loss from operations for the three months ended June 30, 2010 were $750,000 compared to $445,000 for the three months ended June 30, 2009.

16 Aug 2010

Scientists replace human gene to preserve photoreceptor function in retinal degeneration

The easy accessibility of the eye and the established link between specific genetic defects and ocular disorders offer hope for using gene therapy to provide long-term therapeutic benefit. Two reports in the current issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc., describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration. The articles are available free online.

16 Aug 2010

Allscripts commences public offering on behalf of Misys plc

Allscripts-Misys Healthcare Solutions, Inc., the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.

16 Aug 2010

Inovio Pharmaceuticals 2010 second quarter net loss decreases

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010.Total revenue was $1.1 million and $2.5 million for the three and six months ended June 30, 2010, compared to $2.5 million and $2.9 million for the three and six months ended June 30, 2009, respectively.

16 Aug 2010

National Mentor Holdings third-quarter revenue increases 6.1% to $259.7 million

National Mentor Holdings, Inc. today announced its financial results for the third quarter ended June 30, 2010.

16 Aug 2010

Medicare disability recipient dies of brain tumor after having coverage interrupted

Milwaukee Journal Sentinel: "Paula Oertel, whose brain tumor disappeared for nine years while she was on an expensive drug and returned after she temporarily lost her insurance coverage, has died as a result of the tumor spreading through her brain. The interruption of her Medicare coverage of the drug directly contributed to her death, contends her doctor, Mark Malkin, chief of neuro-oncology at Froedtert Hospital.

16 Aug 2010

Nymox second-quarter net loss increases to $1.75 million

Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.

16 Aug 2010